Australia's most trusted
source of pharma news
Monday, 07 October 2024
Posted 13 September 2024 AM
Corporate reputation and leadership are "extremely influential" when healthcare practitioners are deciding which medicine to prescribe, a new survey has discovered.
WE Communications questioned 540 HCPs across Australia, China, Germany, India, United Kingdom and the United States with the results revealing a direct connection between corporate reputation and prescribing decisions.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.